These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16340309)

  • 1. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.
    Paulson QX; McArthur MJ; Johnson DG
    Cell Cycle; 2006 Jan; 5(2):184-90. PubMed ID: 16340309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
    Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
    Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice.
    Chen Q; Liang D; Overbeek PA
    Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis.
    Paulson QX; Pusapati RV; Hong S; Weaks RL; Conti CJ; Johnson DG
    Oncogene; 2008 Aug; 27(36):4954-61. PubMed ID: 18469863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
    Wang D; Russell J; Xu H; Johnson DG
    Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
    Wang D; Russell JL; Johnson DG
    Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc lacks E2F1's ability to suppress skin carcinogenesis.
    Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
    Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
    Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
    Pierce AM; Fisher SM; Conti CJ; Johnson DG
    Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Arf/p53 tumor surveillance network by E2F.
    Iaquinta PJ; Aslanian A; Lees JA
    Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
    Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
    Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a.
    Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R
    PLoS Biol; 2007 Jul; 5(7):e179. PubMed ID: 17608565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
    Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
    Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis.
    Hong S; Paulson QX; Johnson DG
    Cell Cycle; 2008 Feb; 7(3):391-400. PubMed ID: 18235226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice.
    Liao Y; Du W
    J Biol Chem; 2018 Mar; 293(9):3156-3167. PubMed ID: 29330306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
    Wu L; de Bruin A; Wang H; Simmons T; Cleghorn W; Goldenberg LE; Sites E; Sandy A; Trimboli A; Fernandez SA; Eng C; Shapiro C; Leone G
    Oncogene; 2015 Jan; 34(1):119-28. PubMed ID: 24276244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.